![MMAE-[d8]](https://resource.bocsci.com/structure/2070009-72-0.gif)
Inquiry Basket
CAS No.: 103848-61-9
Cat No.: BADC-00505
Purity: ≥98%
4.5 
6-Maleimidocaproic acid sulfo-NHS is a small molecule reagent used in the biomedical industry. It is commonly used to modify biomolecules, such as proteins and antibodies, for site-specific conjugation. This compound enables the efficient and stable attachment of drugs, tags, or targeting moieties to these biomolecules, thereby facilitating the development of innovative treatments for a variety of diseases, including cancer and autoimmune diseases.
Structure of 103848-61-9
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
6-Maleimidocaproic acid sulfo-NHS, a highly reactive crosslinking reagent, is extensively utilized in biochemical and biotechnological applications. Here are four key applications of this compound, presented with a high degree of perplexity and burstiness:
Protein Labeling: Serving as a fundamental tool in protein research, 6-Maleimidocaproic acid sulfo-NHS plays a crucial role in covalently attaching fluorescent dyes or other labels to proteins. By interacting with free amine groups on proteins, it facilitates precise and durable labeling essential for various analytical techniques like fluorescence microscopy and flow cytometry. This capability enhances the ability to monitor and analyze protein dynamics within diverse cellular environments, unveiling new dimensions in the exploration of protein function.
Antibody Conjugation: At the heart of therapeutic and diagnostic pursuits, this reagent is pivotal in skillfully conjugating antibodies with drugs, toxins, or enzymes. Through the formation of steadfast thioether bonds with sulfhydryl groups, it ensures targeted and effective delivery of the conjugated molecules. This application stands as a cornerstone in advancing targeted cancer therapies and developing diagnostic assays, ushering in new possibilities for precision medicine and disease detection.
Surface Immobilization: In the realms of biosensing and biochip technologies, 6-Maleimidocaproic acid sulfo-NHS emerges as a critical agent for immobilizing biomolecules onto various surfaces. By establishing a durable linkage between the biomolecule and the sensor surface, it enhances the sensitivity and specificity of biosensing devices. This functionality proves particularly crucial in creating diagnostic tools capable of detecting biomarkers and pathogens, heralding a new era in rapid and accurate disease diagnosis.
Protein-Protein Interaction Studies: Unveiling the intricacies of cellular signaling and molecular dynamics, this crosslinking reagent is invaluable for probing protein-protein interactions. By bridging proteins in close proximity, it empowers researchers to unravel and delineate intricate interaction networks crucial for understanding complex biological processes.
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-01624 | 6-Maleimidocaproic acid | 55750-53-3 |
6-Maleimidocaproic acid sulfo-NHS
Required fields are marked with *
6-Maleimidocaproic acid sulfo-NHS
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
